Most Recently Approved Drugs Target Genetic Diseases and Cancer
The field of cellular and genetic therapies is rapidly progressing. Since the start of 2023, many novel medications have received
FDA approval, including treatments for solid tumors and hematologic malignancies, as well as rare genetic disorders.
Prescribing Volume for Certain Drug Classes Has Increased
While e-prescribing of antidepressants (-4.5%), stimulants (7.4%) and opioids (-24.3%) changed in 2022
from 2021, the share of total prescribing was higher for antidepressants (1.3%) and stimulants (11.2%) but
lower for opioids (-3.6%).
Health sector employment
Why I Practice Value-based Care in a Rural Health Community
When I graduated from residency as a family practice provider, I began my career in a rural health practice. I was not prepared for the depth and kindness of the patients and their families, the multiple generations that I would care for, nor the deep roots I would put into the community. I was also […]
National, Federal and State Policy Updates: November 1, 2022
National, Federal and State Policy Updates: November 2022 Federal Policy Updates CMS Announces BPCI-A Extension through 2025 On October 13, CMS stated that the Bundled Payments for Care Improvement Advanced (BPCI-A) Model would be extended for another 2 years, and will now end on December 31, 2025. The model ties Medicare payments to episodes […]
National, Federal and State Policy Updates: October 1, 2022
National, Federal and State Policy Updates: October 2022 Federal Policy Updates Congress Passes Continuing Resolution with FDA Reauthorization On September 30, Congress passed a continuing resolution to fund the government through December 16, when a full funding bill for fiscal year 2023 must be reached. The bill included important legislation for FDA user fee […]
Fast Company: “Strategic partnerships in health care services: An untapped resource for accelerating growth”
Fast Company: “Strategic partnerships in health care services: An untapped resource for accelerating growth” Roy Bejarano, Co-Founder and CEO of SCALE Healthcare Strategic partnerships are one of health care’s most underdeveloped value-creation strategies, despite providing organizations with a rich ecosystem ripe with creative growth tactics. As the health care market matures and continues to evolve, securing […]
National, Federal and State Policy Updates: September 1, 2022
National, Federal and State Policy Updates: September 2022 Federal Policy Updates CMS Releases 2021 MSSP Performance Data On August 30, CMS released financial and quality data for the Medicare Shared Savings Program (MSSP) including metrics on accountable care organizations’ (ACOs) expenditures, spending benchmarks, shared savings and losses, and aggregated beneficiary and provider information. Relative to […]
National, Federal and State Policy Updates: August 1, 2022
National, Federal and State Policy Updates: July 20, 2022 Spotlight on Pediatrics On August 1, CMS outlined a roadmap for a new state Medicaid option in a federal guidance document on a health home benefit for children with complex medical conditions. Health homes are a way for states to provide home-based services for those with […]
SCALE Healthcare Announces Expansion Plans with the Addition of Six New Subsidiaries and the Launch of a New Online Healthcare Education Program
SCALE Healthcare has quickly risen in the US to become the leader in healthcare services consulting through its singular focus on helping management teams build modernized healthcare delivery systems that yield superior market results NEW YORK (PRWEB) JULY 21, 2022 SCALE Healthcare, the nation’s premier healthcare management consulting firm, today announced the addition of six new subsidiaries […]